Intensive antiplatelet therapy with three agents does not reduce risk of another stroke
- PMID: 31712390
- DOI: 10.1136/dtb.2019.000058
Intensive antiplatelet therapy with three agents does not reduce risk of another stroke
Keywords: adherence; adverse effects.
Conflict of interest statement
Competing interests: None declared. Disclosure of conflicts of interest form(s) are published online as supplementary files.
Comment on
-
Antiplatelet therapy with aspirin, clopidogrel, and dipyridamole versus clopidogrel alone or aspirin and dipyridamole in patients with acute cerebral ischaemia (TARDIS): a randomised, open-label, phase 3 superiority trial.Lancet. 2018 Mar 3;391(10123):850-859. doi: 10.1016/S0140-6736(17)32849-0. Epub 2017 Dec 20. Lancet. 2018. PMID: 29274727 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical